化合物Colivelin|TP1856|TargetMol

Colivelin
867021-83-8

￥1820 1mg 起订

￥4710 5mg 起订

￥7260 10mg 起订

上海更新日期：2024-12-12

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 化合物Colivelin

英文名称：: Colivelin

CAS号：: 867021-83-8

品牌：: TargetMol

产地：: 美国

保存条件：: keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 96.56%

产品类别：: 抑制剂

货号：: TP1856

Product Introduction

Bioactivity

Name	Colivelin
Description	Colivelin is a neuroprotective peptide and activator of STAT3. Colivelin is a hybrid peptide synthesized to enhance the neuroprotective effects of humanin (HN).
Storage	keep away from moisture \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	Ethanol : < 1 mg/mL (Insoluble or slightly soluble) PBS : < 1 mg/mL (Insoluble or slightly soluble) 5% DMSO+40% PEG300+5% Tween 80+50% Saline : 1 mg/mL (0.38 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. DMSO : 50 mg/mL (18.90 mM), Sonication is recommended.
Keywords	Amyloid-β \| β-amyloid peptide \| STAT \| Inhibitor \| inhibit \| disease \| Neuroprotectant \| Abeta \| ischemic \| brain \| neurological \| Colivelin \| alzheimer \| injury
Inhibitors Related	Rutin \| Methyl tridecanoate \| Nifuroxazide \| Diosgenin \| Niclosamide olamine \| CASIN \| Tramiprosate \| Deferoxamine Mesylate \| Niclosamide \| Balsalazide sodium hydrate
Related Compound Libraries	Anti-Cancer Compound Library \| Transcription Factor-Targeted Compound Library \| Anti-Alzheimer's Disease Compound Library \| JAK-STAT Compound Library \| Peptide Compound Library \| Stem Cell Differentiation Compound Library \| NO PAINS Compound Library \| Anti-Neurodegenerative Disease Compound Library \| Reprogramming Compound Library

Colivelin|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务